Predictive Oncology Inc.

1.08
0.12 (12.82%)
At close: Apr 24, 2025, 3:59 PM
1.09
0.93%
After-hours: Apr 24, 2025, 07:55 PM EDT
12.82%
Bid 0.97
Market Cap 9.65M
Revenue (ttm) 1.66M
Net Income (ttm) -12.66M
EPS (ttm) -1.99
PE Ratio (ttm) -0.54
Forward PE 11.15
Analyst n/a
Ask 1.1
Volume 188,097
Avg. Volume (20D) 2,883,986
Open 0.98
Previous Close 0.96
Day's Range 0.98 - 1.08
52-Week Range 0.55 - 3.06
Beta 1.11

About POAI

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery usi...

Sector Healthcare
IPO Date May 3, 2010
Employees 23
Stock Exchange NASDAQ
Ticker Symbol POAI
Full Company Profile
2 weeks ago
-2.19%
Renovaro and Predictive Oncology shares are tradin... Unlock content with Pro Subscription
1 month ago
+50.89%
Predictive Oncology shares are trading higher after the company announced it developed predictive models from 21 compounds from the Natural Products Discovery Core at the University of Michigan Life Sciences Institute.